Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Hameln pharma plus gmbh,Langes Feld 13,31789 Hameln, Germany
Dobutamine 5 mg/ml solution for infusion.
| Pharmaceutical Form |
|---|
|
Solution for infusion. The product is a clear, colourless or almost colourless solution. |
Each ampoule/vial Dobutamine contains dobutamine hydrochloride corresponding to 250 mg dobutamine.
50 ml ampoule/vial
1 ml contains 5 mg dobutamine.
Excipient with known effect: This medicine contains less than 1mmol sodium (23 mg) per 1 ml, that is to say essentially “sodium-free”.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Dobutamine |
Dobutamine is a synthetic, sympathomimetic amine, structurally related to isoproterenol and dopamine, and is administered as racemate. The positive inotropic effect is primarily based on the agonistic effect on cardiac beta1-receptors but also on cardiac alpha1-receptors. |
| List of Excipients |
|---|
|
Sodium metabisulfite (E223) |
Dobutamine 5 mg/ml (250 mg in 50 ml) ampoules made of colourless, neutral glass, type I Ph.Eur.
1, 5 and 10 ampoules with 50 ml solution for infusion.
Dobutamine 5 mg/ml (250 mg in 50 ml) vials made of colourless, neutral glass, type I Ph. Eur, with rubber stopper, Ph.Eur.
1, 5, 10 and 20 vials with 50 ml solution for infusion.
Not all pack sizes may be marketed.
Hameln pharma plus gmbh,Langes Feld 13,31789 Hameln, Germany
PL 25215/0004
13/02/2006 / 13/02/2011
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
